Cargando…
A Framework to Predict the Molecular Classification and Prognosis of Breast Cancer Patients and Characterize the Landscape of Immune Cell Infiltration
It is known that all current cancer therapies can only benefit a limited proportion of patients; thus, molecular classification and prognosis evaluation are critical for correctly classifying breast cancer patients and selecting the best treatment strategy. These processes usually involve the disclo...
Autores principales: | Zheng, Kun, Luo, Zhiyong, Zhou, Yilu, Zhang, Lili, Wang, Yali, Chen, Xiuqiong, Yao, Shuo, Xiong, Huihua, Yuan, Xianglin, Zou, Yanmei, Wang, Yihua, Xiong, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201713/ https://www.ncbi.nlm.nih.gov/pubmed/35720039 http://dx.doi.org/10.1155/2022/4635806 |
Ejemplares similares
-
Association Between RSK2 and Clinical Indexes of Primary Breast Cancer: A Meta-Analysis Based on mRNA Microarray Data
por: Zheng, Kun, et al.
Publicado: (2021) -
Multi-omics consensus portfolio to refine the classification of lung adenocarcinoma with prognostic stratification, tumor microenvironment, and unique sensitivity to first-line therapies
por: Zou, Yanmei, et al.
Publicado: (2022) -
PARP Inhibitor Upregulates PD-L1 Expression and Provides a New Combination Therapy in Pancreatic Cancer
por: Wang, Yali, et al.
Publicado: (2021) -
KRAS
(G12C) mutation‐induced TOPK overexpression contributes to tumour progression in non‐small cell lung cancer
por: Cai, Chang, et al.
Publicado: (2023) -
Bioinformatics analysis identifies COL1A1, THBS2 and SPP1 as potential predictors of patient prognosis and immunotherapy response in gastric cancer
por: Wang, Yali, et al.
Publicado: (2021)